Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07066709 · ClinicalTrials.gov registry record · Phase 2
Painful Post-Operative Hip Study
A Phase 2 study of Unilateral Hip Arthroscopy, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT07066709: Recruiting Phase 2 study of Unilateral Hip Arthroscopy, sponsored by University of Wisconsin, Madison.
NCT07066709 is a Phase 2 study of Unilateral Hip Arthroscopy that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 15 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07066709, a Phase 2 study of Unilateral Hip Arthroscopy, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management. Participants will complete one PET/MRI scan.
Primary Outcome
Images will be taken using FDG PET/MRI to identify the number of lesions in the hip.
Conditions Studied
Interventions
- COMBINATION_PRODUCT FDG PET/MRI
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-01-21 |
| Est. Completion | 2026-11 |
| Phase | Phase 2 |
What NCT07066709 shows while recruiting
NCT07066709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (89% lower).
The record links to 1 condition, with Unilateral Hip Arthroscopy appearing as the primary indexed condition, and to 1 intervention - of which FDG PET/MRI is the first listed.
NCT07066709 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT07066709 about?
NCT07066709 is a clinical study titled "Painful Post-Operative Hip Study". The goal of this clinical trial is to learn if the hips of people who undergo revision hip arthroscopy look different from the hips of people whose hip pain is resolved with the first hip arthroscopy and of people who choose the steroid injection for pain management. Participants will complete one ...
What is the current status of trial NCT07066709?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2026-01-21. Estimated completion is 2026-11.
What conditions does trial NCT07066709 study?
This clinical trial studies the following conditions: Unilateral Hip Arthroscopy.
What interventions are being tested in trial NCT07066709?
The interventions under investigation include: FDG PET/MRI (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07066709?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07066709 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07066709's enrollment target sits among peer trials
15 1920th of 2000 higher than 60 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI